@article {Jerafi-Vider2020.06.17.155028, author = {Ayelet Jerafi-Vider and Noga Moshe and Gideon Hen and Daniel Splittstoesser and Masahiro Shin and Nathan Lawson and Karina Yaniv}, title = {VEGFC induced cell cycle arrest mediates sprouting and differentiation of venous and lymphatic endothelial cells}, elocation-id = {2020.06.17.155028}, year = {2020}, doi = {10.1101/2020.06.17.155028}, publisher = {Cold Spring Harbor Laboratory}, abstract = {The emergence and growth of new vessels requires a tight synchronization between proliferation, differentiation and sprouting, traditionally thought to be controlled by mitogenic signals, especially of the VEGF family. However, how these cues are differentially transduced, by sometimes even neighboring endothelial cells (ECs), remains unclear. Here we identify cell-cycle progression as a new regulator of EC sprouting and differentiation. Using transgenic zebrafish illuminating cell-cycle stages, we show that venous and lymphatic precursors sprout from the Cardinal Vein (CV) exclusively in G0/G1, and reveal that cell-cycle arrest is induced in these ECs by p53 and the CDK-inhibitors p27 and p21. Moreover, we demonstrate that in vivo, chemical and genetic cell-cycle inhibition, results in massive vascular growth. Mechanistically, we identify the mitogenic VEGFC/VEGFR3/ERK axis as direct inducer of cell-cycle arrest in angiogenic ECs and characterize the cascade of events governing venous vs. lymphatic segregation and sprouting. Overall, our results uncover an unexpected mechanism whereby mitogen-controlled cell-cycle arrest boosts sprouting, raising important questions about the use of cell-cycle inhibitors in pathological angiogenesis and lymphangiogenesis.Competing Interest StatementThe authors have declared no competing interest.}, URL = {https://www.biorxiv.org/content/early/2020/06/18/2020.06.17.155028}, eprint = {https://www.biorxiv.org/content/early/2020/06/18/2020.06.17.155028.full.pdf}, journal = {bioRxiv} }